Latest News for: prva

Edit

PRVA Q3 Deep Dive: Acquisition and Value-Based Care Expansion Shape Outlook

The Call 07 Nov 2025
PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million ... Is now the time to buy PRVA? Find out in our full research report (it’s free for active Edge members).
Edit

PRVA 3Q'25 Slide Presentation 11625 (Privia Health Group Inc)

Public Technologies 06 Nov 2025
). 3rd Quarter 2025 Results. Parth Mehrotra, CEO David Mountcastle, CFO. November 6, 2025. Agenda. Key Highlights. 3Q and Year-to-Date Performance. Updated 2025 Guidance and Outlook. Q&A. Very Strong Third Quarter and Year-to-Date Performance ... 3Q'24 ... 3Q'24.
Edit

Privia Health (NASDAQ:PRVA) Surprises With Strong Q3

The Call 06 Nov 2025
PRVA) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million ... Privia Health (PRVA) Q3 CY2025 Highlights. ... PRVA) is a technology-driven company that ...
Edit

Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks

The Call 21 Oct 2025
PRVA) ... Privia Health (NASDAQ. PRVA) ... PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models ... This print exceeded analysts’ expectations by 10.9% ... Best Q2.
  • 1

Article Search

tools
×
×
×
×